A peer-education intervention to reduce injection risk behaviors for HIV and hepatitis C virus infection in young injection drug users
To evaluate whether a behavioral intervention, which taught peer education skills, could reduce injection and sexual risk behaviors associated with primary HIV and hepatitis C virus infection (HCV) among young injection drug users (IDU). We conducted a randomized controlled trial involving HIV and H...
Saved in:
Published in | AIDS (London) Vol. 21; no. 14; pp. 1923 - 1932 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Hagerstown, MD
Lippincott Williams & Wilkins
12.09.2007
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | To evaluate whether a behavioral intervention, which taught peer education skills, could reduce injection and sexual risk behaviors associated with primary HIV and hepatitis C virus infection (HCV) among young injection drug users (IDU).
We conducted a randomized controlled trial involving HIV and HCV antibody-negative IDU, aged 15-30 years, recruited in five United States cities. A six-session, small-group, cognitive behavioral, skills-building intervention in which participants were taught peer education skills (n = 431) was compared with a time-equivalent attention control (n = 423). Baseline visits included interviews for sociodemographic, psychosocial, and behavioral factors during the previous 3 months; HIV and HCV antibody testing; and pre/posttest counselling. Procedures were repeated 3 and 6 months postintervention.
The intervention produced a 29% greater decline in overall injection risk 6 months postintervention relative to the control [proportional odds ratio 0.71; 95% confidence limit (CL) 0.52, 0.97], and a 76% decrease compared with baseline. Decreases were also observed for sexual risk behaviors, but they did not differ by trial arm. Overall HCV infection incidence (18.4/100 person-years) did not differ significantly across trial arms (relative risk 1.15; 95% CL 0.72, 1.82). No HIV seroconversions were observed.
Interventions providing information, enhancing risk-reduction skills, and motivating behavior change through peer education training can reduce injection risk behaviors, although risk elimination might be necessary to prevent HCV transmission. |
---|---|
AbstractList | To evaluate whether a behavioral intervention, which taught peer education skills, could reduce injection and sexual risk behaviors associated with primary HIV and hepatitis C virus infection (HCV) among young injection drug users (IDU).
We conducted a randomized controlled trial involving HIV and HCV antibody-negative IDU, aged 15-30 years, recruited in five United States cities. A six-session, small-group, cognitive behavioral, skills-building intervention in which participants were taught peer education skills (n = 431) was compared with a time-equivalent attention control (n = 423). Baseline visits included interviews for sociodemographic, psychosocial, and behavioral factors during the previous 3 months; HIV and HCV antibody testing; and pre/posttest counselling. Procedures were repeated 3 and 6 months postintervention.
The intervention produced a 29% greater decline in overall injection risk 6 months postintervention relative to the control [proportional odds ratio 0.71; 95% confidence limit (CL) 0.52, 0.97], and a 76% decrease compared with baseline. Decreases were also observed for sexual risk behaviors, but they did not differ by trial arm. Overall HCV infection incidence (18.4/100 person-years) did not differ significantly across trial arms (relative risk 1.15; 95% CL 0.72, 1.82). No HIV seroconversions were observed.
Interventions providing information, enhancing risk-reduction skills, and motivating behavior change through peer education training can reduce injection risk behaviors, although risk elimination might be necessary to prevent HCV transmission. Objectives: To evaluate whether a behavioral intervention, which taught peer education skills, could reduce injection and sexual risk behaviors associated with primary HIV and hepatitis C virus infection (HCV) among young injection drug users (IDU). Design: We conducted a randomized controlled trial involving HIV and HCV antibody-negative IDU, aged 15-30 years, recruited in five United States cities. A six-session, small-group, cognitive behavioral, skills-building intervention in which participants were taught peer education skills (n=431) was compared with a time-equivalent attention control (n=423). Baseline visits included interviews for sociodemographic, psychoso-cial, and behavioral factors during the previous 3 months; HIV and HCV antibody testing; and pre/posttest counselling. Procedures were repeated 3 and 6 months postintervention. Results: The intervention produced a 29% greater decline in overall injection risk 6 months postintervention relative to the control [proportional odds ratio 0.71; 95% confidence limit (CL) 0.52, 0.97], and a 76% decrease compared with baseline. Decreases were also observed for sexual risk behaviors, but they did not differ by trial arm. Overall HCV infection incidence (18.4/100 person-years) did not differ significantly across trial arms (relative risk 1.15; 95% CL 0.72, 1.82). No HIV seroconversions were observed. Conclusion: Interventions providing information, enhancing risk-reduction skills, and motivating behavior change through peer education training can reduce injection risk behaviors, although risk elimination might be necessary to prevent HCV transmission. |
Author | THIEDE, Hanne LATKA, Mary H GOLUB, Elizabeth T OUELLET, Lawrence J PURCELL, David W GREENBERG, Alan E STRATHDEE, Steffanie A HAGAN, Holly HANSON, Debra L HUDSON, Sharon M KAPADIA, Farzana GARFEIN, Richard S |
Author_xml | – sequence: 1 givenname: Richard S surname: GARFEIN fullname: GARFEIN, Richard S organization: Division of HIV/AIDS Prevention, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, United States – sequence: 2 givenname: Elizabeth T surname: GOLUB fullname: GOLUB, Elizabeth T organization: Johns Hopkins University, Bloomberg School of Public Health, Baltimore, Maryland, United States – sequence: 3 givenname: Steffanie A surname: STRATHDEE fullname: STRATHDEE, Steffanie A organization: University of California San Diego, School of Medicine, San Diego, California, United States – sequence: 4 givenname: Hanne surname: THIEDE fullname: THIEDE, Hanne organization: Public Health Seattle and King County, Seattle, Washington, United States – sequence: 5 givenname: Alan E surname: GREENBERG fullname: GREENBERG, Alan E organization: Division of HIV/AIDS Prevention, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, United States – sequence: 6 givenname: Holly surname: HAGAN fullname: HAGAN, Holly organization: National Research and Development Institutes, New York, New York, United States – sequence: 7 givenname: Debra L surname: HANSON fullname: HANSON, Debra L organization: Division of HIV/AIDS Prevention, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, United States – sequence: 8 givenname: Sharon M surname: HUDSON fullname: HUDSON, Sharon M organization: Health Research Association, Los Angeles, California, United States – sequence: 9 givenname: Farzana surname: KAPADIA fullname: KAPADIA, Farzana organization: New York Academy of Medicine, Center for Urban Epidemiologic Studies, New York, New York, United States – sequence: 10 givenname: Mary H surname: LATKA fullname: LATKA, Mary H organization: New York Academy of Medicine, Center for Urban Epidemiologic Studies, New York, New York, United States – sequence: 11 givenname: Lawrence J surname: OUELLET fullname: OUELLET, Lawrence J organization: University of Illinois at Chicago, School of Public Health, Chicago, Illinois, United States – sequence: 12 givenname: David W surname: PURCELL fullname: PURCELL, David W organization: Division of HIV/AIDS Prevention, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, United States |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=19135567$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/17721100$$D View this record in MEDLINE/PubMed |
BookMark | eNpdkE1PGzEQhq0KVBLgH1SVL-1tYWzv2tljFMqHhISQgOvKa48T08RO7d1I_AF-NxtYiYrTaGae9z08U3IQYkBCfjA4Y1Cr8_v5xRm0wAQKPuPC1SDlNzJhpRJFVSl2QCbAZV3UQsERmeb8DAAVzGbfyRFTijMGMCGvc7pFTAXa3ujOx0B96DDtMLwvXaRp_8Lh_Izm_ZZ8_ktbXOmdjylTFxO9vnmiOli6wu1Q0vlMF3TnU5-HmBtjPtCX2Iflf0029UvaZ0z5hBw6vc54Os5j8nj552FxXdzeXd0s5reFKRnvipY5AIecG6OkrWcW21Y5WzuhJJZKi4rXEtEow7SWUlpujbWtdq0smdFGHJPfH73bFP_1mLtm47PB9VoHjH1uOAOhyooPYPkBmhRzTuiabfIbnV4aBs3efzP4b776H2I_x_6-3aD9DI3CB-DXCOhs9NolHYzPn1zNRFVJJd4AGBWUYw |
CitedBy_id | crossref_primary_10_1111_j_1478_3231_2011_02494_x crossref_primary_10_1016_j_drugalcdep_2009_07_005 crossref_primary_10_21859_nmj_25025 crossref_primary_10_1177_2325957415613442 crossref_primary_10_1016_j_asoc_2012_02_020 crossref_primary_10_3109_10826084_2011_521466 crossref_primary_10_1016_j_drugalcdep_2015_03_002 crossref_primary_10_1080_09540121_2022_2085868 crossref_primary_10_1080_13548506_2010_498890 crossref_primary_10_1007_s11524_015_9995_7 crossref_primary_10_3109_10826081003682875 crossref_primary_10_1007_s10461_013_0601_2 crossref_primary_10_1016_j_jsat_2014_07_002 crossref_primary_10_1186_s12889_021_12104_w crossref_primary_10_3109_10826080903452439 crossref_primary_10_3109_10826084_2012_644122 crossref_primary_10_1093_ofid_ofz160 crossref_primary_10_1016_j_vaccine_2024_05_076 crossref_primary_10_1136_bmjopen_2013_002581 crossref_primary_10_1371_journal_pone_0228471 crossref_primary_10_2174_1874613601004030105 crossref_primary_10_1002_cl2_1264 crossref_primary_10_1111_dar_13134 crossref_primary_10_1007_s11524_015_9988_6 crossref_primary_10_1186_s12954_018_0245_7 crossref_primary_10_1016_j_drugpo_2013_03_004 crossref_primary_10_1136_bmjopen_2020_041482 crossref_primary_10_1016_j_drugpo_2018_02_004 crossref_primary_10_1007_s10461_018_2293_0 crossref_primary_10_1097_OLQ_0b013e318186dee3 crossref_primary_10_3390_ijerph19073783 crossref_primary_10_1186_s12954_017_0142_5 crossref_primary_10_1016_S2468_1253_23_00018_3 crossref_primary_10_1016_j_drugpo_2023_104250 crossref_primary_10_1016_j_drugalcdep_2013_08_007 crossref_primary_10_1016_j_meegid_2018_05_028 crossref_primary_10_1007_s10461_021_03275_z crossref_primary_10_1007_s10461_009_9569_3 crossref_primary_10_1007_s10461_017_1755_0 crossref_primary_10_1016_j_socscimed_2008_09_061 crossref_primary_10_2105_AJPH_2007_113415 crossref_primary_10_1556_oh_2010_28860 crossref_primary_10_1016_j_drugalcdep_2007_05_007 crossref_primary_10_1016_j_drugpo_2008_02_015 crossref_primary_10_1007_s12664_013_0407_1 crossref_primary_10_1093_cid_ciu698 crossref_primary_10_1186_s12954_017_0192_8 crossref_primary_10_1371_journal_pmed_1000329 crossref_primary_10_1371_journal_pone_0065812 crossref_primary_10_1111_j_1360_0443_2011_03765_x crossref_primary_10_1080_02739615_2023_2231339 crossref_primary_10_1016_j_drugpo_2014_07_013 crossref_primary_10_1371_journal_pone_0019048 crossref_primary_10_1016_j_drugpo_2011_08_002 crossref_primary_10_1080_09540121_2010_525608 crossref_primary_10_2174_1874613601206010259 crossref_primary_10_1177_009145091003700405 crossref_primary_10_3748_wjg_v20_i36_12722 crossref_primary_10_1186_s12954_016_0108_z crossref_primary_10_1007_s10461_011_9943_9 crossref_primary_10_1080_15381501_2016_1244653 crossref_primary_10_1007_s10461_013_0488_y crossref_primary_10_1097_QAD_0b013e3282f3cc5d crossref_primary_10_1186_s12879_020_05003_9 crossref_primary_10_1002_jmv_23252 crossref_primary_10_1016_j_vaccine_2010_08_085 crossref_primary_10_1007_s11904_021_00556_z crossref_primary_10_4137_SART_S580 crossref_primary_10_1177_009145091003700407 crossref_primary_10_1007_s10461_011_0125_6 crossref_primary_10_1017_S0950268812000696 crossref_primary_10_1371_journal_pone_0131712 crossref_primary_10_1007_s10461_013_0660_4 crossref_primary_10_1186_1471_2458_10_401 crossref_primary_10_1016_j_drugalcdep_2011_10_009 crossref_primary_10_11604_pamj_2019_34_214_12851 crossref_primary_10_1007_s10461_012_0373_0 crossref_primary_10_1016_j_socscimed_2008_11_019 crossref_primary_10_1007_s10461_017_1774_x crossref_primary_10_1097_QAD_0b013e3282f3cc4d crossref_primary_10_1016_j_drugalcdep_2007_08_010 crossref_primary_10_1016_j_addbeh_2017_07_017 crossref_primary_10_1111_j_1360_0443_2011_03749_x crossref_primary_10_1007_s10461_020_03115_6 crossref_primary_10_1093_infdis_jiq111 crossref_primary_10_1007_s11524_012_9718_2 crossref_primary_10_1016_j_drugpo_2022_103930 crossref_primary_10_1136_bmjopen_2014_004988 crossref_primary_10_1177_1090198109357319 crossref_primary_10_1016_j_drugalcdep_2007_11_020 crossref_primary_10_1016_j_socscimed_2013_07_006 crossref_primary_10_1186_1747_597X_7_47 crossref_primary_10_1016_j_drugpo_2021_103319 crossref_primary_10_1016_j_addbeh_2015_01_020 crossref_primary_10_1007_s10903_009_9308_x crossref_primary_10_3310_hta21720 crossref_primary_10_1016_j_genhosppsych_2010_02_001 crossref_primary_10_1016_j_epidem_2008_10_002 crossref_primary_10_1097_QAD_0b013e3283467198 crossref_primary_10_1371_journal_pone_0183354 crossref_primary_10_1016_j_drugpo_2014_01_009 crossref_primary_10_1071_NB10007 crossref_primary_10_3389_fpsyt_2022_905314 crossref_primary_10_1186_s12954_023_00789_8 crossref_primary_10_1186_1471_2458_12_653 crossref_primary_10_1002_14651858_CD007381_pub2 crossref_primary_10_1177_0017896916641459 crossref_primary_10_1016_j_addbeh_2011_03_014 crossref_primary_10_1093_infdis_jir196 crossref_primary_10_1002_14651858_CD012021_pub2 crossref_primary_10_1186_1471_2458_14_645 crossref_primary_10_1111_j_1360_0443_2010_03251_x crossref_primary_10_1186_1471_2458_11_610 |
Cites_doi | 10.1136/bmj.38286.841227.7C 10.5694/j.1326-5377.1993.tb137822.x 10.1006/pmed.1994.1056 10.1093/aje/152.2.99 10.2105/AJPH.81.5.568 10.1097/00005792-199507000-00005 10.1111/j.1360-0443.1997.tb02852.x 10.1017/CBO9780511814365 10.1097/00002030-199204000-00013 10.1016/S0899-3289(01)00071-2 10.1093/oxfordjournals.aje.a116489 10.1086/345554 10.1007/s10461-005-1679-y 10.2105/AJPH.91.1.42 10.1001/archinte.161.10.1281 10.1016/j.drugalcdep.2004.01.014 10.1097/01.aids.0000196166.48518.a0 10.1111/j.1360-0443.2004.00963.x 10.1136/jech.57.4.310 10.1097/00042560-199802001-00004 10.1093/aje/155.7.645 10.1126/science.280.5365.867 10.1097/00002030-199008000-00020 10.1037/0033-2909.111.3.455 10.1136/bmj.317.7156.433 10.1093/jurban/jtg078 10.2105/AJPH.81.2.168 10.1001/archinte.1995.00430120091011 10.1093/oxfordjournals.aje.a116275 10.1111/j.1360-0443.1993.tb02094.x 10.2105/AJPH.82.4.533 10.2105/AJPH.86.5.655 10.1016/S0140-6736(98)07026-3 10.1056/NEJM200107053450107 10.1097/00002030-199305000-00017 10.1093/her/7.3.403 10.1093/aje/kwf222 10.1056/NEJM198909283211306 10.2307/2529876 10.2307/1912557 10.1016/S0140-6736(00)04562-1 |
ContentType | Journal Article |
Copyright | 2007 INIST-CNRS |
Copyright_xml | – notice: 2007 INIST-CNRS |
CorporateAuthor | DUIT Study Team |
CorporateAuthor_xml | – name: DUIT Study Team |
DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7T2 7T5 7U1 7U2 7U9 C1K H94 |
DOI | 10.1097/QAD.0b013e32823f9066 |
DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Health and Safety Science Abstracts (Full archive) Immunology Abstracts Risk Abstracts Safety Science and Risk Virology and AIDS Abstracts Environmental Sciences and Pollution Management AIDS and Cancer Research Abstracts |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Risk Abstracts Virology and AIDS Abstracts AIDS and Cancer Research Abstracts Health & Safety Science Abstracts Immunology Abstracts Safety Science and Risk Environmental Sciences and Pollution Management |
DatabaseTitleList | MEDLINE Risk Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1473-5571 |
EndPage | 1932 |
ExternalDocumentID | 10_1097_QAD_0b013e32823f9066 17721100 19135567 |
Genre | Randomized Controlled Trial Research Support, U.S. Gov't, P.H.S Journal Article |
GeographicLocations | United States North America America USA |
GeographicLocations_xml | – name: United States – name: USA |
GrantInformation_xml | – fundername: PHS HHS grantid: U64/CCU017615 – fundername: PHS HHS grantid: U64/CCU317662 – fundername: PHS HHS grantid: U64 CCU217659 – fundername: PHS HHS grantid: U64/CCU517656 – fundername: PHS HHS grantid: U64/CCU917655 |
GroupedDBID | --- .GJ .XZ .Z2 01R 08R 0R~ 1CY 1J1 23M 2WC 354 40H 4Q1 4Q2 4Q3 53G 5GY 5RE 5VS 71W 77Y 7O~ 85S 8L- AAAXR AAGIX AAHPQ AAJCS AAMOA AAMTA AAPBV AAQKA AARTV AASOK AASXQ AAXQO ABASU ABBUW ABDIG ABIVO ABXVJ ABZAD ACCJW ACDDN ACEWG ACGFS ACILI ACOAL ACWDW ACWRI ACXNZ ADBBV ADFPA ADGGA ADNKB AE3 AE6 AEBDS AEETU AENEX AFDTB AFFNX AFUWQ AGINI AHOMT AHRYX AHVBC AIJEX AJIOK AJNWD AJNYG AKALU AKULP ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI AOHHW AWKKM BAWUL BOYCO BQLVK BS7 BYPQX C45 CAG COF CS3 DIK DIWNM DUNZO E.X E3Z EBS EEVPB EJD EX3 F2K F2L F2M F2N F5P FCALG FL- FW0 GNXGY GQDEL H0~ HZ~ IKREB IKYAY IN~ IPNFZ IQODW JF9 JG8 JK3 JK8 K8S KD2 KMI KQ8 L-C L7B N4W N9A N~7 N~B N~M O9- OAG OAH OBH OCUKA ODA ODMTH OHH OHYEH OJAPA OK1 OL1 OLB OLG OLH OLU OLV OLW OLY OLZ OPUJH OPX ORVUJ OUVQU OVD OVDNE OVIDH OVLEI OVOZU OWU OWV OWW OWX OWY OWZ OXXIT P-K P2P R58 RIG RLZ S4R S4S SJN T8P TEORI TR2 TSPGW UAP V2I VVN W3M WOQ WOW X3V X3W XJT XXN XYM YFH ZGI ZXP ZZMQN AAAAV AAIQE AAUEB ABJNI ADHPY AFEXH AHQNM AINUH AJZMW CGR CUY CVF ECM EIF NPM AASCR AAYXX ABVCZ ACXJB AFSOK CITATION ERAAH HLJTE 7T2 7T5 7U1 7U2 7U9 C1K H94 |
ID | FETCH-LOGICAL-c412t-b1f00fe22cc76d98debb7fd9f376e47a35296eec7c1aa666d2dcddbafb641cac3 |
ISSN | 0269-9370 |
IngestDate | Fri Oct 25 12:15:03 EDT 2024 Fri Aug 23 00:26:48 EDT 2024 Tue Oct 15 23:29:14 EDT 2024 Sun Oct 22 16:04:58 EDT 2023 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 14 |
Keywords | Intravenous administration Hepatic disease Epidemiology Incidence Education Behavior Viral hepatitis C injection drug use Human Immunopathology Drug addiction AIDS peer education Immune deficiency randomized controlled trial Infection Virus HIV Viral disease Young adult Risk factor Digestive diseases Flaviviridae Hepatitis C virus Hepacivirus Arm |
Language | English |
License | CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c412t-b1f00fe22cc76d98debb7fd9f376e47a35296eec7c1aa666d2dcddbafb641cac3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://doi.org/10.1097/qad.0b013e32823f9066 |
PMID | 17721100 |
PQID | 21037452 |
PQPubID | 23462 |
PageCount | 10 |
ParticipantIDs | proquest_miscellaneous_21037452 crossref_primary_10_1097_QAD_0b013e32823f9066 pubmed_primary_17721100 pascalfrancis_primary_19135567 |
PublicationCentury | 2000 |
PublicationDate | 2007-09-12 |
PublicationDateYYYYMMDD | 2007-09-12 |
PublicationDate_xml | – month: 09 year: 2007 text: 2007-09-12 day: 12 |
PublicationDecade | 2000 |
PublicationPlace | Hagerstown, MD |
PublicationPlace_xml | – name: Hagerstown, MD – name: England |
PublicationTitle | AIDS (London) |
PublicationTitleAlternate | AIDS |
PublicationYear | 2007 |
Publisher | Lippincott Williams & Wilkins |
Publisher_xml | – name: Lippincott Williams & Wilkins |
References | 17721105 - AIDS. 2007 Sep 12;21(14):1967-9 18097240 - AIDS. 2008 Jan 11;22(2):319; author reply 319 Crepaz (R55-12-20210130) 2006; 20 Becker Buxton (R48-12-20210130) 2004; 75 Crofts (R3-12-20210130) 1993; 159 Watkins (R29-12-20210130) 1993; 7 Bandura (R42-12-20210130) 1986 Strathdee (R15-12-20210130) 2001; 161 Strathdee (R32-12-20210130) 1997; 92 Wolfinger (R52-12-20210130) 2004 Neaigus (R31-12-20210130) 1995 Barnard (R30-12-20210130) 1993; 88 Judd (R7-12-20210130) 2005; 330 Turner (R45-12-20210130) 1998; 280 Smyth (R6-12-20210130) 2003; 57 Koester (R13-12-20210130) 2005; 9 Nicolosi (R19-12-20210130) 1992; 135 Lauer (R56-12-20210130) 2001; 345 Stephens (R25-12-20210130) 1991; 81 Fisher (R43-12-20210130) 1992; 111 Des Jarlais (R46-12-20210130) 1999; 353 Kral (R17-12-20210130) 2001; 357 Thorpe (R10-12-20210130) 2002; 155 Van Ameijden (R20-12-20210130) 1992; 136 McClusker (R26-12-20210130) 1992; 82 Hagan (R9-12-20210130) 2001; 91 Garfein (R18-12-20210130) 1998; 18 Metzger (R47-12-20210130) 2000; 152 Nelson (R21-12-20210130) 1995; 155 Vuong (R54-12-20210130) 1989; 57 Laird (R51-12-20210130) 1982; 38 Kelly (R34-12-20210130) 1991; 81 Schoenbaum (R14-12-20210130) 1989; 321 Thomas (R4-12-20210130) 1995; 74 Grund (R12-12-20210130) 1990; 4 Kauth (R37-12-20210130) 1993; 34 Des Jarlais (R23-12-20210130) 2003; 157 Hahn (R11-12-20210130) 2002; 186 McCullagh (R50-12-20210130) 1980; 42 Cameron (R53-12-20210130) 1998 Sullivan (R1-12-20210130) 2005; 100 (R41-12-20210130) 2001; 50 Main (R38-12-20210130) 1994; 23 Broadhead (R39-12-20210130) 1998; 113 Hansen (R36-12-20210130) 1992; 7 Van Beek (R8-12-20210130) 1998; 317 Garfein (R5-12-20210130) 1996; 86 Strathdee (R16-12-20210130) 2003; 80 Chamot (R2-12-20210130) 1992; 6 Neaigus (R24-12-20210130) 1990; 2 Latkin (R35-12-20210130) 1998; 113 Latka (R22-12-20210130) 2001; 13 |
References_xml | – volume: 330 start-page: 24 year: 2005 ident: R7-12-20210130 article-title: Incidence of hepatitis C virus and HIV among new injecting drug users in London: prospective cohort study publication-title: BMJ doi: 10.1136/bmj.38286.841227.7C contributor: fullname: Judd – volume: 159 start-page: 237 year: 1993 ident: R3-12-20210130 article-title: Hepatitis C virus infection among a cohort of Victorian injecting drug users publication-title: Med J Aust doi: 10.5694/j.1326-5377.1993.tb137822.x contributor: fullname: Crofts – volume: 23 start-page: 409 year: 1994 ident: R38-12-20210130 article-title: Preventing HIV infection among adolescents: evaluation of a school-based education program publication-title: Prev Med doi: 10.1006/pmed.1994.1056 contributor: fullname: Main – volume: 152 start-page: 99 year: 2000 ident: R47-12-20210130 article-title: Randomized controlled trial of audio computer-assisted self-interviewing: utility and acceptability in longitudinal studies. HIVNET Vaccine Preparedness Study Protocol Team publication-title: Am J Epidemiol doi: 10.1093/aje/152.2.99 contributor: fullname: Metzger – volume: 81 start-page: 568 year: 1991 ident: R25-12-20210130 article-title: Effects of an intervention program on AIDS-related drug and needle behavior among intravenous drug users publication-title: Am J Public Health doi: 10.2105/AJPH.81.5.568 contributor: fullname: Stephens – volume: 74 start-page: 212 year: 1995 ident: R4-12-20210130 article-title: Correlates of hepatitis C virus infection among injection drug users publication-title: Medicine doi: 10.1097/00005792-199507000-00005 contributor: fullname: Thomas – volume: 92 start-page: 1339 year: 1997 ident: R32-12-20210130 article-title: Social determinants predicting needle-sharing behavior among injection drug users in Vancouver, Canada publication-title: Addiction doi: 10.1111/j.1360-0443.1997.tb02852.x contributor: fullname: Strathdee – year: 1998 ident: R53-12-20210130 article-title: Regression analysis of count data doi: 10.1017/CBO9780511814365 contributor: fullname: Cameron – volume: 6 start-page: 430 year: 1992 ident: R2-12-20210130 article-title: Incidence of hepatitis C, hepatitis B and HIV infections among drug users in a methadone-maintenance programme publication-title: AIDS doi: 10.1097/00002030-199204000-00013 contributor: fullname: Chamot – volume: 13 start-page: 73 year: 2001 ident: R22-12-20210130 article-title: Prevalence, incidence, and correlates of chlamydia and gonorrhea among young adult injection drug users publication-title: J Subst Abuse doi: 10.1016/S0899-3289(01)00071-2 contributor: fullname: Latka – volume: 136 start-page: 236 year: 1992 ident: R20-12-20210130 article-title: The harm reduction approach and risk factors for human immunodeficiency virus (HIV) seroconversion in injection drug users, Amsterdam publication-title: Am J Epidemiol doi: 10.1093/oxfordjournals.aje.a116489 contributor: fullname: Van Ameijden – volume: 186 start-page: 1558 year: 2002 ident: R11-12-20210130 article-title: Hepatitis C virus seroconversion among young injection drug users: relationship and risk publication-title: J Infect Dis doi: 10.1086/345554 contributor: fullname: Hahn – volume: 9 start-page: 27 year: 2005 ident: R13-12-20210130 article-title: Drug sharing among heroin networks: implications for HIV and hepatitis B and C prevention publication-title: AIDS Behav doi: 10.1007/s10461-005-1679-y contributor: fullname: Koester – start-page: 20 year: 1995 ident: R31-12-20210130 article-title: Using dyadic data for a network analysis of HIV infection and risk behaviors among injecting drug users contributor: fullname: Neaigus – volume: 91 start-page: 42 year: 2001 ident: R9-12-20210130 article-title: Sharing of drug preparation equipment as a risk factor for hepatitis C publication-title: Am J Public Health doi: 10.2105/AJPH.91.1.42 contributor: fullname: Hagan – year: 2004 ident: R52-12-20210130 article-title: Fitting nonlinear mixed models with the new NLMIXED procedure, version 9.1 software contributor: fullname: Wolfinger – volume: 161 start-page: 1281 year: 2001 ident: R15-12-20210130 article-title: Sex differences in risk factors for HIV seroconversion among injection drug users: a 10-year perspective publication-title: Arch Intern Med doi: 10.1001/archinte.161.10.1281 contributor: fullname: Strathdee – volume: 75 start-page: 177 year: 2004 ident: R48-12-20210130 article-title: Association between injection practices and duration of injection among recently initiated injection drug users publication-title: Drug Alcohol Depend doi: 10.1016/j.drugalcdep.2004.01.014 contributor: fullname: Becker Buxton – volume: 20 start-page: 143 year: 2006 ident: R55-12-20210130 article-title: Do prevention interventions reduce HIV risk behaviours among people living with HIV? A meta-analytic review of controlled trials publication-title: AIDS doi: 10.1097/01.aids.0000196166.48518.a0 contributor: fullname: Crepaz – volume: 100 start-page: 150 year: 2005 ident: R1-12-20210130 article-title: Decreasing international HIV transmission: the role of expanding access to opioid agonist therapies for injection drug users publication-title: Addiction doi: 10.1111/j.1360-0443.2004.00963.x contributor: fullname: Sullivan – volume: 57 start-page: 310 year: 2003 ident: R6-12-20210130 article-title: Retrospective cohort study examining incidence of HIV and hepatitis C infection among injecting drug users in Dublin publication-title: J Epidemiol Commun Health doi: 10.1136/jech.57.4.310 contributor: fullname: Smyth – volume: 18 start-page: S11 year: 1998 ident: R18-12-20210130 article-title: Prevalence and incidence of hepatitis C virus infection among young adult injection drug users publication-title: J Acquir Immune Defic Syndr doi: 10.1097/00042560-199802001-00004 contributor: fullname: Garfein – volume: 155 start-page: 645 year: 2002 ident: R10-12-20210130 article-title: Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment publication-title: Am J Epidemiol doi: 10.1093/aje/155.7.645 contributor: fullname: Thorpe – volume: 34 start-page: 346 year: 1993 ident: R37-12-20210130 article-title: HIV sexual risk reduction among college women: applying a peer influence model publication-title: J College Stud Dev contributor: fullname: Kauth – volume: 280 start-page: 867 year: 1998 ident: R45-12-20210130 article-title: Adolescent sexual behavior, drug use, and violence: increased reporting with computer survey technology publication-title: Science doi: 10.1126/science.280.5365.867 contributor: fullname: Turner – volume: 4 start-page: 819 year: 1990 ident: R12-12-20210130 article-title: The limitations of the concept of needle sharing: the practice of ‘frontloading’ publication-title: AIDS doi: 10.1097/00002030-199008000-00020 contributor: fullname: Grund – volume: 50 start-page: 1 issue: RR-19 year: 2001 ident: R41-12-20210130 article-title: Revised guidelines for HIV counseling, testing, and referral and revised recommendations for HIV screening of pregnant women. publication-title: MMWR Recomm Rep – volume: 111 start-page: 455 year: 1992 ident: R43-12-20210130 article-title: Changing AIDS-risk behavior publication-title: Psychol Bull doi: 10.1037/0033-2909.111.3.455 contributor: fullname: Fisher – volume: 317 start-page: 433 year: 1998 ident: R8-12-20210130 article-title: Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: retrospective cohort study publication-title: BMJ doi: 10.1136/bmj.317.7156.433 contributor: fullname: Van Beek – volume: 80 start-page: iii7 year: 2003 ident: R16-12-20210130 article-title: The role of sexual transmission of HIV infection among injection and noninjection drug users publication-title: J Urban Health doi: 10.1093/jurban/jtg078 contributor: fullname: Strathdee – volume: 81 start-page: 168 year: 1991 ident: R34-12-20210130 article-title: HIV risk behavior reduction following intervention with key opinion leaders of population: an experimental analysis publication-title: Am J Public Health doi: 10.2105/AJPH.81.2.168 contributor: fullname: Kelly – volume: 155 start-page: 1305 year: 1995 ident: R21-12-20210130 article-title: Temporal trends of incident HIV infection in a cohort of injection drug users in Baltimore, Maryland publication-title: Arch Intern Med doi: 10.1001/archinte.1995.00430120091011 contributor: fullname: Nelson – volume: 135 start-page: 225 year: 1992 ident: R19-12-20210130 article-title: Parenteral and sexual transmission of human immunodeficiency virus in intravenous drug users: a study of seroconversion. The North Italian Seronegative Drug Addicts (NISDA) Study publication-title: Am J Epidemiol doi: 10.1093/oxfordjournals.aje.a116275 contributor: fullname: Nicolosi – volume: 88 start-page: 805 year: 1993 ident: R30-12-20210130 article-title: Needle sharing in context: patterns of sharing among men and women injectors and HIV risks publication-title: Addiction doi: 10.1111/j.1360-0443.1993.tb02094.x contributor: fullname: Barnard – volume: 82 start-page: 533 year: 1992 ident: R26-12-20210130 article-title: AIDS education for drug users: evaluation of short-term effectiveness publication-title: Am J Public Health doi: 10.2105/AJPH.82.4.533 contributor: fullname: McClusker – year: 1986 ident: R42-12-20210130 article-title: Social foundations of thought and action contributor: fullname: Bandura – volume: 86 start-page: 655 year: 1996 ident: R5-12-20210130 article-title: Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses publication-title: Am J Public Health doi: 10.2105/AJPH.86.5.655 contributor: fullname: Garfein – volume: 353 start-page: 1657 year: 1999 ident: R46-12-20210130 article-title: Audio-computer interviewing to measure risk behaviour for HIV among injecting drug users: a quasi-randomised trial publication-title: Lancet doi: 10.1016/S0140-6736(98)07026-3 contributor: fullname: Des Jarlais – volume: 345 start-page: 41 year: 2001 ident: R56-12-20210130 article-title: Hepatitis C virus infection publication-title: N Engl J Med doi: 10.1056/NEJM200107053450107 contributor: fullname: Lauer – volume: 7 start-page: 719 year: 1993 ident: R29-12-20210130 article-title: Determinants of condom use among intravenous drug users publication-title: AIDS doi: 10.1097/00002030-199305000-00017 contributor: fullname: Watkins – volume: 2 start-page: 253 year: 1990 ident: R24-12-20210130 article-title: Effects of outreach intervention on risk reduction among intravenous drug users publication-title: AIDS Educ Prev contributor: fullname: Neaigus – volume: 7 start-page: 403 year: 1992 ident: R36-12-20210130 article-title: School-based substance abuse prevention: a review of the state of the art in curriculum, 1980–1990 publication-title: Health Educ Res doi: 10.1093/her/7.3.403 contributor: fullname: Hansen – volume: 157 start-page: 467 year: 2003 ident: R23-12-20210130 article-title: Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City publication-title: Am J Epidemiol doi: 10.1093/aje/kwf222 contributor: fullname: Des Jarlais – volume: 321 start-page: 874 year: 1989 ident: R14-12-20210130 article-title: Risk factors for human immunodeficiency virus infection in intravenous drug users publication-title: N Engl J Med doi: 10.1056/NEJM198909283211306 contributor: fullname: Schoenbaum – volume: 38 start-page: 963 year: 1982 ident: R51-12-20210130 article-title: Random-effects models for longitudinal data publication-title: Biometrics doi: 10.2307/2529876 contributor: fullname: Laird – volume: 42 start-page: 109 year: 1980 ident: R50-12-20210130 article-title: Regression models for ordinal data (with discussion) publication-title: JR Stat Soc Ser B Stat Meth contributor: fullname: McCullagh – volume: 113 start-page: 151 issue: Suppl 1 year: 1998 ident: R35-12-20210130 article-title: Outreach in natural settings: the use of peer leaders for HIV prevention among injecting drug users' networks publication-title: Public Health Rep contributor: fullname: Latkin – volume: 113 start-page: 42 year: 1998 ident: R39-12-20210130 article-title: Harnessing peer networks as an instrument for AIDS prevention: results from a peer-driven intervention publication-title: Public Health Rep contributor: fullname: Broadhead – volume: 57 start-page: 307 year: 1989 ident: R54-12-20210130 article-title: Likelihood ratio tests for model selection and nonnested hypotheses publication-title: Econometrica doi: 10.2307/1912557 contributor: fullname: Vuong – volume: 357 start-page: 1397 year: 2001 ident: R17-12-20210130 article-title: Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis publication-title: Lancet doi: 10.1016/S0140-6736(00)04562-1 contributor: fullname: Kral |
SSID | ssj0005088 |
Score | 2.3185341 |
Snippet | To evaluate whether a behavioral intervention, which taught peer education skills, could reduce injection and sexual risk behaviors associated with primary HIV... Objectives: To evaluate whether a behavioral intervention, which taught peer education skills, could reduce injection and sexual risk behaviors associated with... |
SourceID | proquest crossref pubmed pascalfrancis |
SourceType | Aggregation Database Index Database |
StartPage | 1923 |
SubjectTerms | Adolescent Adolescent Behavior - psychology Adult Behavior Therapy - methods Biological and medical sciences Drug addictions Female Health Education - methods Hepatitis C - epidemiology Hepatitis C - prevention & control Hepatitis C virus HIV Infections - epidemiology HIV Infections - prevention & control Human immunodeficiency virus Human viral diseases Humans Incidence Infectious diseases Male Medical sciences Peer Group Risk Reduction Behavior Sexual Behavior - psychology Substance Abuse, Intravenous - epidemiology Substance Abuse, Intravenous - psychology Toxicology Treatment Outcome United States - epidemiology Viral diseases Viral diseases of the lymphoid tissue and the blood. Aids Viral hepatitis |
Title | A peer-education intervention to reduce injection risk behaviors for HIV and hepatitis C virus infection in young injection drug users |
URI | https://www.ncbi.nlm.nih.gov/pubmed/17721100 https://search.proquest.com/docview/21037452 |
Volume | 21 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9RAFB7WCiKIeO96qfPgWxhNJpfZPIZt7VapILbQtzDXtlJ2l2wi6A_w9_gTPTO5l1WsLyEkZEhyvpz55uQ75yD0ZgYsOpaxJJKGMYko94kwihHpq8TVm0upTU4-_pQsTqMPZ_HZZPJroFqqSvFW_tiaV_I_VoVjYFebJXsDy3aDwgHYB_vCFiwM23-yceattS6IbkUarvhDp2AEVlnYU7YsyFddtwR3SvI2Nd-VYvAWsAC00fMLbcXV5eXGm3vfLouqF2o5MeR36xYGI6miOvdsiGMz5LfZ0f6XYZeQLsxwyAvT9NVscvn7oOshvCQx0pj10m2nC2o1aNkVeKOD3mme19Hbhe2XPQpfMOLaLwy8HE1SAhzJH7rkOmm6hV40cLCWkA4ma0s_t04EdYHhz9l-G-mFpWVoUj_ZUnf72nzYqRTb__MwSn59lFvoNgXX5oQBRx97UZHvOp12D9Uma6bs3bZ7GZGhe2u-ge_S1A1V_rzicczn5AG63yxZcFbj7yGa6OUjdOe4EWU8Rj8zPIYhHsIQlytcwxB34MEWhriDIQYYYoAhBhjiDoZ4jh0McQdD2MMOhoORLAyxg-ETdPr-4GS-IE17DyKjgJZEBMb3jaZUSpaodKa0EMyo1MCcpyPGQysJ0FoyGXAOq2xFlVRKcCOSKJBchk_RznK11LsIKyYt9ZQmlToSKeWhMWEoZazjdDbjYopI-57zdV3FJf-bdadob2SM_qI0AIKesCl63VonB39sf7LxpV5Vm5zaxNsoplP0rDZafy1z0Rb_-Q1v5gW62384L9FOWVT6FTDhUuw58P0GYxm0xQ |
link.rule.ids | 315,783,787,27936,27937 |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+peer-education+intervention+to+reduce+injection+risk+behaviors+for+HIV+and+hepatitis+C+virus+infection+in+young+injection+drug+users&rft.jtitle=AIDS+%28London%29&rft.au=Garfein%2C+Richard+S&rft.au=Golub%2C+Elizabeth+T&rft.au=Greenberg%2C+Alan+E&rft.au=Hagan%2C+Holly&rft.date=2007-09-12&rft.issn=0269-9370&rft.volume=21&rft.issue=14&rft.spage=1923&rft.epage=1932&rft_id=info:doi/10.1097%2FQAD.0b013e32823f9066&rft.externalDBID=n%2Fa&rft.externalDocID=10_1097_QAD_0b013e32823f9066 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0269-9370&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0269-9370&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0269-9370&client=summon |